FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harvey Alter

Research Profile

Disorders

Living Beings

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Lu Deng; Hongying Duan; Stephen Feinstone; Christine Harman; Li Ma; Evi Struble; Maria Luisa Virata-Theimer; Hailing Yan; Zhong Zhao; Lilin Zhong; Harvey Alter; Pei Zhang
Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus.
Harvey Alter
Baruch Blumberg (1925-2011).
Philip Meuleman; Jens Bukh; Lieven Verhoye; Ali Farhoudi; Thomas Vanwolleghem; Richard Y Wang; Isabelle Desombere; Harvey Alter; Robert H Purcell; Geert Leroux-Roels
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harvey Alter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lu Deng; Hongying Duan; Stephen Feinstone; Christine Harman; Li Ma; Evi Struble; Maria Luisa Virata-Theimer; Hailing Yan; Zhong Zhao; Lilin Zhong; Harvey Alter; Pei Zhang
Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(18):7418-22.
2011: Harvey Alter
Baruch Blumberg (1925-2011).
Nature 2011;473(7346):155.
2011: Philip Meuleman; Jens Bukh; Lieven Verhoye; Ali Farhoudi; Thomas Vanwolleghem; Richard Y Wang; Isabelle Desombere; Harvey Alter; Robert H Purcell; Geert Leroux-Roels
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.
Hepatology (Baltimore, Md.) 2011;53(3):755-62.
2011: R Loomba; M M Rivera; R McBurney; Y Park; V Haynes-Williams; B Rehermann; Harvey Alter; Steven K Herrine; TSANYANG LIANG; Jay H Hoofnagle; Theo Heller
The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes.
Alimentary pharmacology & therapeutics 2011;33(5):559-65.
2009: Jennifer Daniel-Johnson; Susan F Leitman; HARVEY KLEIN; Harvey Alter; Agnes Lee-Stroka; Phillip Scheinberg; Jeremy Pantin; Karen Quillen
Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.
Transfusion 2009;49(9):1845-9.
2009: Robert D Allison; Antonios Katsounas; Deloris Koziol; David E Kleiner; Harvey Alter; Richard A Lempicki; Brad Wood; Jun Yang; Brandie Fullmer; Karoll J Cortez; Michael A Polis; Shyam Kottilil
Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV.
The Journal of infectious diseases 2009;200(4):619-23.
2009: Zhen-Yong Keck; Sophia H Li; Jinming Xia; Thomas von Hahn; Peter Balfe; Jane A McKeating; Jeroen Witteveldt; Arvind H Patel; Harvey Alter; Charles M Rice; Steven K H Foung
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
Journal of virology 2009;83(12):6149-60.
2009: Pei Zhang; Lilin Zhong; Evi Budo Struble; Hisayoshi Watanabe; Alla Kachko; Kathleen Mihalik; Maria Luisa Virata-Theimer; Harvey Alter; Stephen M Feinstone; Marian E Major
Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(18):7537-41.
2009: Peter D Burbelo; Alexandra T Issa; Kathryn H Ching; Maurice Exner; W Lawrence Drew; Harvey Alter; Michael Iadarola
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies.
Virology journal 2009;6():45.
2008: Qi Qiu; Richard Yuan-Hu Wang; Xuanmao Jiao; Bo Jin; Fuminaka Sugauchi; Teresa Grandinetti; Harvey Alter; James Shih
Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.
Vaccine 2008;26(43):5527-34.
2008: Harvey Alter; HARVEY KLEIN
The hazards of blood transfusion in historical perspective.
Blood 2008;112(7):2617-26.
2008: Harvey Alter
Management of hepatitis virus infections.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 3():26-32.
2008: Thomas Vanwolleghem; Jens Bukh; Philip Meuleman; Isabelle Desombere; Jean-Christophe Meunier; Harvey Alter; Robert Purcell; Geert Leroux-Roels
Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain.
Hepatology (Baltimore, Md.) 2008;47(6):1846-55.
2008: Harvey Alter
Pathogen reduction: a precautionary principle paradigm.
Transfusion medicine reviews 2008;22(2):97-102.
2008: Troels K H Scheel; Judith M Gottwein; Tanja B Jensen; Jannick C Prentoe; Anne M Hoegh; Harvey Alter; Jesper Eugen-Olsen; Jens Bukh
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(3):997-1002.
2007: Bo Jin; Richard Y-H Wang; Qi Qiu; Fuminaka Sugauchi; Teresa Grandinetti; Harvey Alter; James Shih
Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
Immunology 2007;122(1):15-27.
2007: Pei Zhang; Charles G Wu; Kathleen Mihalik; Maria Luisa Virata-Theimer; Mei-ying W Yu; Harvey Alter; Stephen M Feinstone
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(20):8449-54.
2007: Kousuke Hanada; Yasuhito Tanaka; Masashi Mizokami; Takashi Gojobori; Harvey Alter
A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation.
Virology 2007;361(1):27-33.
2007: Naomi L C Luban; Camilla A Colvin; Parvathi Mohan; Harvey Alter
The epidemiology of transfusion-associated hepatitis C in a children's hospital.
Transfusion 2007;47(4):615-20.
2007: Thomas von Hahn; Joo Chun Yoon; Harvey Alter; Charles M Rice; Barbara Rehermann; Peter Balfe; Jane A McKeating
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
Gastroenterology 2007;132(2):667-78.
2007: Parvathi Mohan; Camilla Colvin; Chevelle Glymph; Roma R Chandra; David E Kleiner; Kantilal M Patel; Naomi L C Luban; Harvey Alter
Clinical spectrum and histopathologic features of chronic hepatitis C infection in children.
The Journal of pediatrics 2007;150(2):168-74, 174.e1.
2007: Ying Huang; Huiying Yang; Brian B Borg; Xiaowen Su; Shannon L Rhodes; Kai Yang; Xiaomei Tong; George Tang; Charles D Howell; Hugo Rosen; Chloe L Thio; David L Thomas; Harvey Alter; Ronda K Sapp; TSANYANG LIANG
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(3):985-90.
2007: Harvey Alter; Susan L Stramer; Roger Y Dodd
Emerging infectious diseases that threaten the blood supply.
Seminars in hematology 2007;44(1):32-41.
2006: Pei Zhang; Mei-ying W Yu; Richard M Venable; Harvey Alter; James Shih
Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(24):9214-9.
2006: Patrizia Farci; Isabella Quinti; Stefania Farci; Harvey Alter; Rita Strazzera; Elvia Palomba; Alessandra Coiana; Daniele Cao; Anna Maria Casadei; Ritarella Ledda; Raffaele Iorio; Angela Vegnente; Giacomo Diaz; Pier-Angelo Tovo
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(22):8475-80.
2006: Yasuhito Tanaka; Fuat Kurbanov; Shuhei Mano; Etsuro Orito; Víctor Vargas; Juan Ignacio Esteban; Man-Fung Yuen; Ching-Lung Lai; Anna Kramvis; Michael C Kew; Heidi E Smuts; Sergey V Netesov; Harvey Alter; Masashi Mizokami
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality.
Gastroenterology 2006;130(3):703-14.
2006: Fuminaka Sugauchi; Richard Y-H Wang; Qi Qiu; Bo Jin; Harvey Alter; James Shih
Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
The Journal of infectious diseases 2006;193(4):563-72.
2006: Harvey Alter
Viral hepatitis.
Hepatology (Baltimore, Md.) 2006;43(2 Suppl 1):S230-4.
2006: Takeji Umemura; Richard Y-H Wang; Cathy Schechterly; James Shih; Kendo Kiyosawa; Harvey Alter
Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2006;43(1):91-9.
2005: Darren Schofield; Birke Bartosch; Yohko K Shimizu; Tobias Allander; Harvey Alter; Suzanne U Emerson; François-Loïc Cosset; Robert Purcell
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
Hepatology (Baltimore, Md.) 2005;42(5):1055-62.
2005: Harvey Alter
HCV natural history: the retrospective and prospective in perspective.
Journal of hepatology 2005;43(4):550-2.
2005: Bo Jin; Harvey Alter; Zhi-Cheng Zhang; James Shih; Juan M Esteban; Tao Sun; Yun-Sheng Yang; Qi Qiu; Xiao-Lin Liu; Lin Yao; Hai-Dong Wang; Liu-Fang Cheng
Reversibility of experimental rabbit liver cirrhosis by portal collagenase administration.
Laboratory investigation; a journal of technical methods and pathology 2005;85(8):992-1002.
2005: Jun Akiba; Takeji Umemura; Harvey Alter; Masamichi Kojiro; Edward Tabor
SEN virus: epidemiology and characteristics of a transfusion-transmitted virus.
Transfusion 2005;45(7):1084-8.
2005: Seiya Momosaki; T Umemura; Charles Scudamore; Masamichi Kojiro; Harvey Alter; Edward Tabor
SEN virus infection in patients with hepatocellular carcinoma.
Journal of viral hepatitis 2005;12(4):435-8.
2005: Kazushi Sugimoto; David Edward Kaplan; Fusao Ikeda; Jin Ding; Jonathan Schwartz; Frederick A Nunes; Harvey Alter; Kyong-Mi Chang
Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection.
Journal of virology 2005;79(11):6976-83.
2005: Lily Lin; Carl V Hanson; Harvey Alter; Valérie Jauvin; Kristen A Bernard; Krishna K Murthy; Peyton Metzel; Laurence Corash
Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light.
Transfusion 2005;45(4):580-90.
2005: Jean-Christophe Meunier; ronald engle; Kristina Faulk; Ming Zhao; Birke Bartosch; Harvey Alter; Suzanne U Emerson; François-Loïc Cosset; Robert Purcell; Jens Bukh
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(12):4560-5.
2004: Carine Logvinoff; Marian E Major; David W Oldach; S Heyward; Andrew H Talal; Peter Balfe; Stephen M Feinstone; Harvey Alter; Charles M Rice; Jane A McKeating
Neutralizing antibody response during acute and chronic hepatitis C virus infection.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(27):10149-54.
2004: Fareed Rahman; Theo Heller; Yuji Sobao; Eishiro Mizukoshi; Michelina Nascimbeni; Harvey Alter; Steven Herrine; Jay H Hoofnagle; TSANYANG LIANG; Barbara Rehermann
Effects of antiviral therapy on the cellular immune response in acute hepatitis C.
Hepatology (Baltimore, Md.) 2004;40(1):87-97.
2004: Harvey Alter
Emerging, re-emerging and submerging infectious threats to the blood supply.
Vox sanguinis 2004;87 Suppl 2():56-61.
2004: Xuanmao Jiao; Richard Yan-Hui Wang; Qi Qiu; Harvey Alter; James Shih
Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes.
The Journal of general virology 2004;85(Pt 6):1545-53.
2004: Yasuhito Tanaka; Ruth Pfeiffer; Anthony E T Yeo; Masashi Mizokami; Brian Edlin; Philip Castle; Thomas R O'Brien; Harvey Alter; James Shih
PCR-probe capture hybridization assay and statistical model for SEN virus prevalence estimation.
Journal of medical virology 2004;73(1):123-30.
2004: Xuanmao Jiao; R Y-H Wang; Z Feng; G Hu; Harvey Alter; J W -K Shih
DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response.
Journal of viral hepatitis 2004;11(1):18-26.
2003: Kazushi Sugimoto; Fusao Ikeda; Jason Stadanlick; Frederick A Nunes; Harvey Alter; Kyong-Mi Chang
Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.
Hepatology (Baltimore, Md.) 2003;38(6):1437-48.
2003: Takeji Umemura; Eiji Tanaka; George Ostapowicz; Kevin E Brown; Stefan Heringlake; Nicolaos C Tassopoulos; Richard Y-H Wang; Anthony E T Yeo; James Shih; Koji Orii; Neal S Young; Angelos Hatzakis; Michael P Manns; William M Lee; Kendo Kiyosawa; Harvey Alter
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis.
The Journal of infectious diseases 2003;188(10):1545-52.
2003: Harvey Alter
The unexpected outcomes of medical research: serendipity and the Australia antigen. Blumberg BS, Alter HJ, Visnich S. A new antigen in leukemia sera [J Am Med Assoc 1965;191:541-546].
Journal of hepatology 2003;39(2):149-52.
2003: Ruth M Pfeiffer; Yasuhito Tanaka; Anthony E T Yeo; Takeji Umemura; Karen Seal; James Shih; Harvey Alter; Brian Edlin; Thomas R O'Brien
Prevalence of SEN viruses among injection drug users in the San Francisco Bay area.
The Journal of infectious diseases 2003;188(1):13-8.
2003: Kazumoto Murata; Martin Lechmann; Ming Qiao; Toshiaki Gunji; Harvey Alter; TSANYANG LIANG
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(11):6753-8.
2003: W Lawrence Drew; Gary Tegtmeier; Harvey Alter; Megan E Laycock; Richard C Miner; Michael P Busch
Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.
Transfusion 2003;43(3):309-13.
2003: Kazushi Sugimoto; Jason Stadanlick; Fusao Ikeda; Colleen Brensinger; Emma E Furth; Harvey Alter; Kyong-Mi Chang
Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response.
Hepatology (Baltimore, Md.) 2003;37(3):590-9.
2003: Kittichai Promrat; David H McDermott; Carlos M Gonzalez; David E Kleiner; Deloris Koziol; Matthew Lessie; Maya N Merrell; Alejandro Soza; Theo Heller; Marc G Ghany; Yoon Park; Harvey Alter; Jay H Hoofnagle; Philip M Murphy; TSANYANG LIANG
Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
Gastroenterology 2003;124(2):352-60.
2003: Xuanmao Jiao; Richard Y-H Wang; Zhiming Feng; Harvey Alter; James Shih
Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization.
Hepatology (Baltimore, Md.) 2003;37(2):452-60.
2003: Marc G Ghany; David E Kleiner; Harvey Alter; Edward Doo; Farooq Khokar; Kittichai Promrat; David Herion; Yoon Park; TSANYANG LIANG; Jay H Hoofnagle
Progression of fibrosis in chronic hepatitis C.
Gastroenterology 2003;124(1):97-104.
2003: Michael Thomson; Michelina Nascimbeni; Michael B Havert; Marian E Major; Sophia Gonzales; Harvey Alter; Stephen M Feinstone; Krishna K Murthy; Barbara Rehermann; TSANYANG LIANG
The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity.
Journal of virology 2003;77(2):862-70.
2002: Yasuhito Tanaka; Kousuke Hanada; Masashi Mizokami; Anthony E T Yeo; James Shih; Takashi Gojobori; Harvey Alter
A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(24):15584-9.
2002: Heiner Wedemeyer; Xiaosong He; Michelina Nascimbeni; Anthony R Davis; Harry B Greenberg; Jay H Hoofnagle; TSANYANG LIANG; Harvey Alter; Barbara Rehermann
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(6):3447-58.
2002: Charles S Rabkin; Beatriz H Tess; Roberta E Christianson; William E Wright; David J Waters; Harvey Alter; Bea J Van Den Berg
Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia.
Blood 2002;99(11):4240-2.
2002: Takeji Umemura; Harvey Alter; Eiji Tanaka; Koji Orii; Anthony E T Yeo; James Shih; Akihiro Matsumoto; Kaname Yoshizawa; Kendo Kiyosawa
SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
Hepatology (Baltimore, Md.) 2002;35(4):953-9.
2002: Patrizia Farci; Rita Strazzera; Harvey Alter; Stefania Farci; Daniela Degioannis; Alessandra Coiana; Giovanna Peddis; Francesco Usai; Giancarlo Serra; Luchino Chessa; Giacomo Diaz; Angelo Balestrieri; Robert Purcell
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):3081-6.
2002: Takeji Umemura; Yasuhito Tanaka; Kendo Kiyosawa; Harvey Alter; James Shih
Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus)(1).
FEBS letters 2002;510(3):171-4.
2001: Lucy E Wilson; T Umemura; Jacquie Astemborski; Stuart C Ray; Harvey Alter; Steffanie A Strathdee; David Vlahov; David L Thomas
Dynamics of SEN virus infection among injection drug users.
The Journal of infectious diseases 2001;184(10):1315-9.
2001: Takeji Umemura; Harvey Alter; Eiji Tanaka; Anthony E T Yeo; James Shih; Koji Orii; Akihiro Matsumoto; Kaname Yoshizawa; Kendo Kiyosawa
Association between SEN virus infection and hepatitis C in Japan.
The Journal of infectious diseases 2001;184(10):1246-51.
2001: Harvey Alter
An unexpected link between HCV and platelets.
Blood 2001;98(8):2291.
2001: Minoru Shibata; R Y Wang; Makoto Yoshiba; James Shih; Harvey Alter; Keiji Mitamura
The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan.
The Journal of infectious diseases 2001;184(4):400-4.
2001: A E Yeo; M Ghany; Cathy Conry-Cantilena; JC Melpolder; David E Kleiner; James Shih; Jay H Hoofnagle; Harvey Alter
Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers.
Journal of viral hepatitis 2001;8(4):256-63.
2001: Takeji Umemura; Anthony E T Yeo; Alessandra Sottini; D Moratto; Y Tanaka; Richard Y-H Wang; James Shih; P Donahue; Daniele Primi; Harvey Alter
SEN virus infection and its relationship to transfusion-associated hepatitis.
Hepatology (Baltimore, Md.) 2001;33(5):1303-11.
2001: Leonard B Seeff; F Blaine Hollinger; Harvey Alter; Elizabeth C Wright; C M Cain; Zelma Buskell; Kamal G Ishak; F L Iber; D Toro; A Samanta; R L Koretz; R P Perrillo; Zachary D Goodman; Robert G Knodell; G Gitnick; Timothy R Morgan; Eugene R Schiff; S Lasky; Cladd E Stevens; R Z Vlahcevic; E Weinshel; T Tanwandee; HJ Lin; LH Barbosa
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
Hepatology (Baltimore, Md.) 2001;33(2):455-63.
2001: Y Tanaka; Daniele Primi; Richard Y-H Wang; Takeji Umemura; Anthony E T Yeo; M Mizokami; Harvey Alter; James Shih
Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family.
The Journal of infectious diseases 2001;183(3):359-67.
2001: D Robert Harris; René Gonin; Harvey Alter; Elizabeth C Wright; Zelma Buskell; F Blaine Hollinger; Leonard B Seeff
The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse.
Annals of internal medicine 2001;134(2):120-4.
2001: Mary E Chamberland; Harvey Alter; Michael P Busch; George Nemo; M Ricketts
Emerging infectious disease issues in blood safety.
Emerging infectious diseases 2001;7(3 Suppl):552-3.
2001: Stephen M Feinstone; A Z Kapikian; Robert Purcell; Harvey Alter; P V Holland
Transfusion-associated hepatitis not due to viral hepatitis type A or B. 1975.
Reviews in medical virology 2001;11(1):3-8; discussion 8-9.
2001: KM Chang; Robert Thimme; J J Melpolder; David W Oldach; Janell Pemberton; J Moorhead-Loudis; J G McHutchison; Harvey Alter; Francis V Chisari
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2001;33(1):267-76.
2000: Harvey Alter; M Houghton
Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis.
Nature medicine 2000;6(10):1082-6.
2000: Eiji Tanaka; C Ohue; K Aoyagi; K Yamaguchi; Shintaro Yagi; Kendo Kiyosawa; Harvey Alter
Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
Hepatology (Baltimore, Md.) 2000;32(2):388-93.
2000: Anthony E T Yeo; A Matsumoto; Michie Hisada; James Shih; Harvey Alter; J J Goedert
Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study.
Annals of internal medicine 2000;132(12):959-63.
2000: Patrizia Farci; A Shimoda; Alessandra Coiana; Giacomo Diaz; Giovanna Peddis; JC Melpolder; A Strazzera; David Chien; Santiago J Munoz; Angelo Balestrieri; Robert Purcell; Harvey Alter
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.
Science (New York, N.Y.) 2000;288(5464):339-44.
2000: Anthony E T Yeo; A Matsumoto; James Shih; Harvey Alter; J J Goedert
Prevalence of hepatitis G virus in patients with hemophilia and their steady female sexual partners.
Sexually transmitted diseases 2000;27(3):178-82.
2000: Robert Purcell; Harvey Alter; J L Dienstag
Non-A, non-B hepatitis. 1976.
The Yale journal of biology and medicine 2000;73(1-6):175-82.
2000: Harvey Alter; L B Seeff
Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.
Seminars in liver disease 2000;20(1):17-35.
2000: Beatriz H Tess; A Levin; G Brubaker; J Shao; James Drummond; Harvey Alter; T R O'Brien
Seroprevalence of hepatitis C virus in the general population of northwest Tanzania.
The American journal of tropical medicine and hygiene 2000;62(1):138-41.
1999: Harvey Alter
Discovery of non-A, non-B hepatitis and identification of its etiology.
The American journal of medicine 1999;107(6B):16S-20S.
1999: Santiago J Muñoz; Harvey Alter; Y Nakatsuji; James Shih; R K Reddy; Lennox Jeffers; Eugene R Schiff; AE Reid; A Marrone; Kenneth D Rothstein; Cosme Manzarbeitia; TSANYANG LIANG
The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology.
Blood 1999;94(4):1460-4.
1999: G J Hu; Richard Y-H Wang; D S Han; Harvey Alter; James Shih
Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization.
Vaccine 1999;17(23-24):3160-70.
1999: Krishna K Murthy; D R Henrard; JW Eichberg; K E Cobb; M P Busch; J P Allain; Harvey Alter
Redefining the HIV-infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission.
Transfusion 1999;39(7):688-93.
1999: A Matsumoto; Anthony E T Yeo; James Shih; E Tanaka; Kendo Kiyosawa; Harvey Alter
Transfusion-associated TT virus infection and its relationship to liver disease.
Hepatology (Baltimore, Md.) 1999;30(1):283-8.
1999: D Tan; A Matsumoto; Cathy Conry-Cantilena; JC Melpolder; James Shih; M Leuther; G Hess; JOAN WHITEHOUSE-GIBBLE; Paul M Ness; Harvey Alter
Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
The Journal of infectious diseases 1999;179(5):1055-61.
1999: Gerald V Quinnan; Peng Fei Zhang; DW Fu; Ming Dong; Harvey Alter
Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response.
AIDS research and human retroviruses 1999;15(6):561-70.
1998: Cathy Conry-Cantilena; JC Melpolder; Harvey Alter; J B Gorlin; K Mascotti
Intranasal drug use among volunteer whole-blood donors: results of survey C.
Transfusion 1998;38(5):512-3.
1998: David L Thomas; David Vlahov; Harvey Alter; J C Hunt; R Marshall; Jacquie Astemborski; Kenrad E Nelson
Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.
The Journal of infectious diseases 1998;177(3):539-42.
1998: Eiji Tanaka; Michael Tacke; Mariko Kobayashi; Y Nakatsuji; Kendo Kiyosawa; S Schmolke; Alfred M Engel; Georg Hess; Harvey Alter
Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic.
Journal of clinical microbiology 1998;36(1):110-4.
1997: Michael Tacke; S Schmolke; V Schlueter; Silvia Sauleda; Juan Ignacio Esteban; Eiji Tanaka; Kendo Kiyosawa; Harvey Alter; Urban Schmitt; Georg Hess; B Ofenloch-Haehnle; Alfred M Engel
Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
Hepatology (Baltimore, Md.) 1997;26(6):1626-33.
1997: A Marrone; James Shih; Y Nakatsuji; Harvey Alter; D Lau; John Vergalla; Jay H Hoofnagle
Serum hepatitis G virus RNA in patients with chronic viral hepatitis.
The American journal of gastroenterology 1997;92(11):1992-6.
1997: X Forns; D Tan; Harvey Alter; Robert Purcell; Jens Bukh
Evaluation of commercially available and in-house reverse transcription-PCR assays for detection of hepatitis G virus or GB virus C.
Journal of clinical microbiology 1997;35(10):2698-702.
1997: Harvey Alter; Cathy Conry-Cantilena; JC Melpolder; D Tan; M Van Raden; David Herion; D Lau; Jay H Hoofnagle
Hepatitis C in asymptomatic blood donors.
Hepatology (Baltimore, Md.) 1997;26(3 Suppl 1):29S-33S.
1997: David L Thomas; Y Nakatsuji; James Shih; Harvey Alter; Kenrad E Nelson; Jacquie Astemborski; CM Lyles; David Vlahov
Persistence and clinical significance of hepatitis G virus infections in injecting drug users.
The Journal of infectious diseases 1997;176(3):586-92.
1997: Harvey Alter
G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus.
Transfusion 1997;37(6):569-72.
1997: Harvey Alter; Y Nakatsuji; JC Melpolder; J Wages; Robert Wesley; James Shih; J P Kim
The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
The New England journal of medicine 1997;336(11):747-54.
1996: Patrizia Farci; A Shimoda; D Wong; T Cabezon; D De Gioannis; A Strazzera; Y Shimizu; M Shapiro; Harvey Alter; Robert Purcell
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15394-9.
1996: Y Nakatsuji; James Shih; E Tanaka; Kendo Kiyosawa; J Wages; JP Kim; Harvey Alter
Prevalence and disease association of hepatitis G virus infection in Japan.
Journal of viral hepatitis 1996;3(6):307-16.
1996: Eiji Tanaka; Harvey Alter; Y Nakatsuji; James Shih; JP Kim; A Matsumoto; Mariko Kobayashi; Kendo Kiyosawa
Effect of hepatitis G virus infection on chronic hepatitis C.
Annals of internal medicine 1996;125(9):740-3.
1996: David L Thomas; James Shih; Harvey Alter; David Vlahov; Sylvia Cohn; D R Hoover; L Cheung; Kenrad E Nelson
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.
The Journal of infectious diseases 1996;174(4):690-5.
1996: Patrizia Farci; Harvey Alter; A Shimoda; Sugantha Govindarajan; L C Cheung; JC Melpolder; R A Sacher; James Shih; Robert Purcell
Hepatitis C virus-associated fulminant hepatic failure.
The New England journal of medicine 1996;335(9):631-4.
1996: Harvey Alter
The cloning and clinical implications of HGV and HGBV-C.
The New England journal of medicine 1996;334(23):1536-7.
1996: Z Chen; I Berkower; W M Ching; R Y Wang; Harvey Alter; James Shih
Identification of a murine CD4+ T-lymphocyte response site in hepatitis C virus core protein.
Molecular immunology 1996;33(7-8):703-9.
1996: Jeffrey Linnen; J Wages; Z Y Zhang-Keck; Kirk Fry; K Z Krawczynski; Harvey Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; Peter Karayiannis; Kevin Fung; Y Nakatsuji; James Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; KC Hyams; S Ismay; Jeffrey D Lifson; Georg Hess; Steven K H Foung; Howard Thomas; D Bradley; H Margolis; JP Kim
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.
Science (New York, N.Y.) 1996;271(5248):505-8.
1995: A O Shakil; Cathy Conry-Cantilena; Harvey Alter; Paul Hayashi; David E Kleiner; V Tedeschi; K Krawczynski; Hari S Conjeevaram; R Sallie; A M Di Bisceglie
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group.
Annals of internal medicine 1995;123(5):330-7.
1995: M P Busch; Harvey Alter
Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost?
Transfusion 1995;35(7):536-9.
1995: David L Thomas; Jonathan M Zenilman; Harvey Alter; James Shih; Noya Galai; A V Carella; Thomas C Quinn
Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships.
The Journal of infectious diseases 1995;171(4):768-75.
1995: Harvey Alter
To C or not to C: these are the questions.
Blood 1995;85(7):1681-95.
1995: Cathy Conry-Cantilena; L Vilamidou; JC Melpolder; M VanRaden; Harvey Alter
Porphyria cutanea tarda in hepatitis C virus-infected blood donors.
Journal of the American Academy of Dermatology 1995;32(3):512-4.
1995: Harvey Alter; D W Bradley
Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC).
Seminars in liver disease 1995;15(1):110-20.
1995: Harvey Alter; R Sanchez-Pescador; MS Urdea; J C Wilber; R J Lagier; A M Di Bisceglie; James Shih; P D Neuwald
Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.
Journal of viral hepatitis 1995;2(3):121-32.
1995: Z Chen; I Berkower; R Y Wang; W M Ching; Harvey Alter; James Shih
Genetic control of the murine humoral response to distinct epitopes of hepatitis C virus core protein.
Journal of viral hepatitis 1995;2(1):9-17.
1994: Patrizia Farci; Harvey Alter; D C Wong; R H Miller; Sugantha Govindarajan; R Engle; Max Shapiro; Robert Purcell
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(16):7792-6.
1994: P Simmonds; A Alberti; Harvey Alter; Ferruccio Bonino; D W Bradley; C Brechot; J T Brouwer; S W Chan; K Chayama; D S Chen
A proposed system for the nomenclature of hepatitis C viral genotypes.
Hepatology (Baltimore, Md.) 1994;19(5):1321-4.
1994: L B Seeff; Harvey Alter
Spousal transmission of the hepatitis C virus?
Annals of internal medicine 1994;120(9):807-9.
1994: Y K Shimizu; M Hijikata; A Iwamoto; Harvey Alter; Robert Purcell; H Yoshikura
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses.
Journal of virology 1994;68(3):1494-500.
1994: Harvey Alter
Transfusion transmitted hepatitis C and non-A, non-B, non-C.
Vox sanguinis 1994;67 Suppl 3():19-24.
1993: W Lu; James Shih; J M Tourani; D Eme; Harvey Alter; Jean-Marie Andrieu
Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients.
AIDS (London, England) 1993;7 Suppl 2():S91-9.
1993: Eduardo Lissen; Harvey Alter; María Antonia Abad; Y Torres; M Pérez-Romero; M Leal; Juan A Pineda; R Torronteras; Armando Sánchez-Quijano
Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(11):827-31.
1993: Richard Y-H Wang; James Shih; Stanley H Weiss; T Grandinetti; P F Pierce; M Lange; Harvey Alter; D J Wear; C L Davies; R K Mayur
Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(4):724-9.
1993: Harvey Alter; James Shih
Probable visualization of the elusive hepatitis C virus.
Hepatology (Baltimore, Md.) 1993;17(6):1164-6.
1993: M Hijikata; Yuko Shimizu; Hirotomo Kato; Aikichi Iwamoto; James Shih; Harvey Alter; Robert Purcell; Hiroshi Yoshikura
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.
Journal of virology 1993;67(4):1953-8.
1992: L B Seeff; Z Buskell-Bales; E C Wright; S J Durako; Harvey Alter; F L Iber; F B Hollinger; G Gitnick; Robert G Knodell; R P Perrillo
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.
The New England journal of medicine 1992;327(27):1906-11.
1992: John F Reinus; E L Leikin; Harvey Alter; L Cheung; M Shindo; B Jett; S Piazza; James Shih
Failure to detect vertical transmission of hepatitis C virus.
Annals of internal medicine 1992;117(11):881-6.
1992: Richard Y-H Wang; James Shih; T Grandinetti; P F Pierce; M M Hayes; D J Wear; Harvey Alter; Shyh-Ching Lo
High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients.
Lancet 1992;340(8831):1312-6.
1992: Steven H Kleinman; Harvey Alter; M Busch; P Holland; G Tegtmeier; M Nelles; S Lee; E Page; J Wilber; A Polito
Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay.
Transfusion 1992;32(9):805-13.
1992: Patrizia Farci; Harvey Alter; Sugantha Govindarajan; D C Wong; R Engle; R R Lesniewski; Isa K Mushahwar; Suresh M Desai; R H Miller; N Ogata
Lack of protective immunity against reinfection with hepatitis C virus.
Science (New York, N.Y.) 1992;258(5079):135-40.
1992: W M Ching; C Wychowski; M J Beach; H Wang; C L Davies; M Carl; D W Bradley; Harvey Alter; S M Feinstone; James Shih
Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3190-4.
1992: J R Hibbs; Norbert Frickhofen; Stephen Rosenfeld; S M Feinstone; S Kojima; A Bacigalupo; A Locasciulli; Andreas G Tzakis; Harvey Alter; Neal S Young
Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C?
JAMA : the journal of the American Medical Association 1992;267(15):2051-4.
1992: D S Vallari; B W Jett; Harvey Alter; L T Mimms; R Holzman; James Shih
Serological markers of posttransfusion hepatitis C viral infection.
Journal of clinical microbiology 1992;30(3):552-6.
1992: Harvey Alter
New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus.
Hepatology (Baltimore, Md.) 1992;15(2):350-3.
1992: Juan Ignacio Esteban; Joan Genesca; Harvey Alter
Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features, and prevention.
Progress in liver diseases 1992;10():253-82.
1992: J M Clemens; S Taskar; K Chau; D Vallari; James Shih; Harvey Alter; J B Schleicher; L T Mimms
IgM antibody response in acute hepatitis C viral infection.
Blood 1992;79(1):169-72.
1991: A M Di Bisceglie; Z D Goodman; K G Ishak; Jay H Hoofnagle; J J Melpolder; Harvey Alter
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.
Hepatology (Baltimore, Md.) 1991;14(6):969-74.
1991: M E Eyster; Harvey Alter; L M Aledort; S Quan; A Hatzakis; J J Goedert
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Annals of internal medicine 1991;115(10):764-8.
1991: Harvey Alter
Descartes before the horse: I clone, therefore I am: the hepatitis C virus in current perspective.
Annals of internal medicine 1991;115(8):644-9.
1991: Harvey Alter; G E Tegtmeier; B W Jett; S Quan; James Shih; W L Bayer; A Polito
The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors.
Transfusion 1991;31(8):771-6.
1991: Kendo Kiyosawa; T Sodeyama; Eiji Tanaka; Y Nakano; S Furuta; K Nishioka; Robert Purcell; Harvey Alter
Hepatitis C in hospital employees with needlestick injuries.
Annals of internal medicine 1991;115(5):367-9.
1991: James Shih; L C Cheung; Harvey Alter; L M Lee; J R Gu
Strain analysis of hepatitis B virus on the basis of restriction endonuclease analysis of polymerase chain reaction products.
Journal of clinical microbiology 1991;29(8):1640-4.
1991: Victor S Blanchette; E Vorstman; A Shore; E Wang; M Petric; B W Jett; Harvey Alter
Hepatitis C infection in children with hemophilia A and B.
Blood 1991;78(2):285-9.
1991: Patrizia Farci; Harvey Alter; D Wong; R H Miller; James Shih; B Jett; Robert Purcell
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
The New England journal of medicine 1991;325(2):98-104.
1991: Joan Genesca; Juan Ignacio Esteban; Harvey Alter
Blood-borne non-A, non-B hepatitis: hepatitis C.
Seminars in liver disease 1991;11(2):147-64.
1991: N Ogata; Harvey Alter; R H Miller; Robert Purcell
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(8):3392-6.
1990: Harvey Alter; Jay S Epstein; S G Swenson; M J VanRaden; J W Ward; Richard A Kaslow; J E Menitove; HARVEY KLEIN; S G Sandler; M H Sayers
Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
The New England journal of medicine 1990;323(19):1312-7.
1990: Joan Genesca; R Y Wang; Harvey Alter; James Shih
Clinical correlation and genetic polymorphism of the human immunodeficiency virus proviral DNA obtained after polymerase chain reaction amplification.
The Journal of infectious diseases 1990;162(5):1025-30.
1990: Yuko Shimizu; AJ Weiner; J Rosenblatt; D C Wong; M Shapiro; T Popkin; Michael Houghton; Harvey Alter; Robert Purcell
Early events in hepatitis C virus infection of chimpanzees.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(16):6441-4.
1990: D B Brettler; Harvey Alter; J L Dienstag; A D Forsberg; P H Levine
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients.
Blood 1990;76(1):254-6.
1990: James E Everhart; A M Di Bisceglie; L M Murray; Harvey Alter; JC Melpolder; G Kuo; Jay H Hoofnagle
Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers.
Annals of internal medicine 1990;112(7):544-5.
1990: W H Zhang; C B Liu; Y D Sun; Harvey Alter; James Shih
Hepatitis C virus causing non-A, non-B hepatitis in plasmapheresis centre.
Lancet 1990;335(8685):353.
1990: James Shih; H H Lee; M Falchek; M Canavaggio; B W Jett; J P Allain; Harvey Alter
Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery.
Blood 1990;75(3):546-9.
1990: Harvey Alter
The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis.
Journal of gastroenterology and hepatology 1990;5 Suppl 1():78-94.
1990: Harvey Alter
Clinical, virological and epidemiological basis for the treatment of chronic non-A, non-B hepatitis.
Journal of hepatology 1990;11 Suppl 1():S19-25.
1989: Harvey Alter; Robert Purcell; James Shih; JC Melpolder; M Houghton; Q L Choo; G Kuo
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
The New England journal of medicine 1989;321(22):1494-500.
1989: Shyh-Ching Lo; M S Dawson; D M Wong; P B Newton; M A Sonoda; W F Engler; Richard Y-H Wang; James Shih; Harvey Alter; D J Wear
Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study.
The American journal of tropical medicine and hygiene 1989;41(5):601-16.
1989: Joan Genesca; James Shih; B W Jett; I K Hewlett; Jay S Epstein; Harvey Alter
What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors?
Lancet 1989;2(8670):1023-5.
1989: W Edward Robinson; D C Montefiori; W M Mitchell; A M Prince; Harvey Alter; G R Dreesman; J W Eichberg
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(12):4710-4.
1989: G Kuo; Q L Choo; Harvey Alter; G L Gitnick; A G Redeker; Robert Purcell; T Miyamura; J L Dienstag; M J Alter; Cladd E Stevens
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.
Science (New York, N.Y.) 1989;244(4902):362-4.
1989: Harvey Alter
Discovery of the non-A, non-B hepatitis virus: the end of the beginning or the beginning of the end.
Transfusion medicine reviews 1989;3(2):77-81.
1989: Joan Genesca; James Shih; J I Esteban; Harvey Alter
Comparison of four different antigen-capture assays for the detection of human immunodeficiency virus antigen (HIV-Ag).
Journal of acquired immune deficiency syndromes 1989;2(2):170-77.
1988: Harvey Alter; R P Creagan; P A Morel; G P Wiesehahn; B P Dorman; Laurence Corash; G C Smith; H Popper; J W Eichberg
Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus.
Lancet 1988;2(8626-8627):1446-50.
1988: Harvey Alter; A M Prince
Transfusion-associated non-A, non-B hepatitis: an assessment of the causative agent and its clinical impact.
Transfusion medicine reviews 1988;2(4):288-93.
1988: F Scheutz; M Melbye; J I Esteban; J Aldershvile; P Ebbesen; Harvey Alter
Hepatitis B virus infection in Danish dentists. A case-control and follow-up study.
American journal of epidemiology 1988;128(1):190-6.
1987: J W Eichberg; J M Zarling; Harvey Alter; J A Levy; Phillip W. Berman; T Gregory; Laurence A Lasky; Janela McClure; K E Cobb; P A Moran
T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees.
Journal of virology 1987;61(12):3804-8.
1987: L F He; D Alling; T Popkin; M Shapiro; Harvey Alter; Robert Purcell
Determining the size of non-A, non-B hepatitis virus by filtration.
The Journal of infectious diseases 1987;156(4):636-40.
1987: W R Berry; R L Gottesfeld; Harvey Alter; J M Vierling
Transmission of hepatitis B virus by artificial insemination.
JAMA : the journal of the American Medical Association 1987;257(8):1079-81.
1987: A H Rook; H Clifford Lane; Thomas M Folks; S McCoy; Harvey Alter; Anthony Fauci
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(4):1064-7.
1987: William Saxinger; Harvey Alter; J W Eichberg; Anthony Fauci; W G Robey; Robert C Gallo
Stages in the progression of HIV infection in chimpanzees.
AIDS research and human retroviruses 1987;3(4):375-85.
1986: S F Leitman; H Boltansky; Harvey Alter; F C Pearson; M A Kaliner
Allergic reactions in healthy plateletpheresis donors caused by sensitization to ethylene oxide gas.
The New England journal of medicine 1986;315(19):1192-6.
1986: M H McGinniss; A M Macher; A H Rook; Harvey Alter
Red cell autoantibodies in patients with acquired immune deficiency syndrome.
Transfusion 1986;26(5):405-9.
1986: D E Koziol; P V Holland; D W Alling; J C Melpolder; R E Solomon; Robert Purcell; L M Hudson; F J Shoup; H Krakauer; Harvey Alter
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.
Annals of internal medicine 1986;104(4):488-95.
1986: J L Dienstag; Harvey Alter
Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.
Seminars in liver disease 1986;6(1):67-81.
1986: James Shih; J I Mur; Harvey Alter
Non-A, non-B hepatitis: advances and unfulfilled expectations of the first decade.
Progress in liver diseases 1986;8():433-52.
1985: J I Esteban; James Shih; C C Tai; A J Bodner; J W Kay; Harvey Alter
Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Lancet 1985;2(8464):1083-6.
1985: I R Mackay; I H Frazer; B H Toh; J S Pedersen; Harvey Alter
Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis.
Clinical and experimental immunology 1985;61(1):39-43.
1985: H Shiraishi; Harvey Alter; S M Feinstone; Robert Purcell
Rheumatoid factor-like reactants in sera proven to transmit non-A, non-B hepatitis: a potential source of false-positive reactions in non-A, non-B assays.
Hepatology (Baltimore, Md.) 1985;5(2):181-7.
1985: J H Hoofnagle; Harvey Alter
Chronic non-A, non-B hepatitis.
Progress in clinical and biological research 1985;182():63-9.
1985: Harvey Alter
Posttransfusion hepatitis: clinical features, risk and donor testing.
Progress in clinical and biological research 1985;182():47-61.
1985: J W Eichberg; Harvey Alter; G R Dreesman
Longitudinal study of HTLV-III-infected chimpanzees by lymphocyte subpopulation analysis.
Journal of medical primatology 1985;14(6):317-26.
1984: Harvey Alter; P V Holland
Indirect tests to detect the non-A, non-B hepatitis carrier state.
Annals of internal medicine 1984;101(6):859-61.
1984: J S Beneke; G E Tegtmeier; Harvey Alter; R B Luetkemeyer; R Solomon; W L Bayer
Relation of titers of antibodies to CMV in blood donors to the transmission of cytomegalovirus infection.
The Journal of infectious diseases 1984;150(6):883-8.
1984: Harvey Alter; J W Eichberg; H Masur; W C Saxinger; Robert C Gallo; A M Macher; H Clifford Lane; Anthony Fauci
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS.
Science (New York, N.Y.) 1984;226(4674):549-52.
1984: Cladd E Stevens; Harvey Alter; Patricia E Taylor; E A Zang; E J Harley; W Szmuness
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
The New England journal of medicine 1984;311(8):496-501.
1984: Baruch S Blumberg; Harvey Alter; S Visnich
Landmark article Feb 15, 1965: A "new" antigen in leukemia sera. By Baruch S. Blumberg, Harvey J. Alter, and Sam Visnich.
JAMA : the journal of the American Medical Association 1984;252(2):252-7.
1983: Stephen M Feinstone; Kathleen Mihalik; T Kamimura; Harvey Alter; W T London; Robert Purcell
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.
Infection and immunity 1983;41(2):816-21.
1983: B A Lenes; P Tomasulo; Harvey Alter; P V Holland
Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis.
The New England journal of medicine 1983;308(12):723.
1982: W Szmuness; Cladd E Stevens; E J Harley; E A Zang; Harvey Alter; Patricia E Taylor; A DeVera; G T Chen; A Kellner
Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
The New England journal of medicine 1982;307(24):1481-6.
1982: W H Dzik; Harvey Alter
Hepatitis B viral infection: Part II. Public health aspects.
American family physician 1982;26(3):135-42.
1982: W H Dzik; Harvey Alter
Hepatitis B viral infection: part I. Clinical features.
American family physician 1982;26(2):119-26.
1982: Harvey Alter
The evolution, implications, and applications of the hepatitis B vaccine.
JAMA : the journal of the American Medical Association 1982;247(16):2272-5.
1981: P V Holland; Harvey Alter
Non-A, non-B viral hepatitis.
Human pathology 1981;12(12):1114-22.
1981: S M Feinstone; Harvey Alter; H P Dienes; Y Shimizu; H Popper; D Blackmore; D Sly; W T London; Robert Purcell
Non-A, non-B hepatitis in chimpanzees and marmosets.
The Journal of infectious diseases 1981;144(6):588-98.
1981: Harvey Alter; T C Chalmers
The HBsAg positive health worker revisited.
Hepatology (Baltimore, Md.) 1981;1(5):467-70.
1981: Harvey Alter; Robert Purcell; P V Holland; D W Alling; D E Koziol
Donor transaminase and recipient hepatitis. Impact on blood transfusion services.
JAMA : the journal of the American Medical Association 1981;246(6):630-4.
1981: Harvey Alter
Hepatitis B: a tribute to nondirected medical research.
Seminars in liver disease 1981;1(1):1-6.
1981: W Szmuness; Cladd E Stevens; E J Harley; E A Zang; Patricia E Taylor; Harvey Alter
The immune response of healthy adults to a reduced dose of hepatitis B vaccine.
Journal of medical virology 1981;8(2):123-9.
1981: K H Burk; G A Cabral; G R Dreesman; R L Peters; Harvey Alter
Ultrastructural changes and virus-like particles localized in liver hepatocytes of chimpanzees infected with non-A, non-B hepatitis.
Journal of medical virology 1981;7(1):1-19.
1980: P Holland; T Golosova; W Szmuness; E Ketiladze; Robert Purcell; P Budnitskaya; R Gerety; T Vorozhbieva; E Harley; V Burlev; Harvey Alter; A Margolina; E Lubashevskaya
Viral hepatitis markers in Soviet and American blood donors.
Transfusion 1980;20(5):504-10.
1980: R M Scott; R Snitbhan; W H Bancroft; Harvey Alter; M Tingpalapong
Experimental transmission of hepatitis B virus by semen and saliva.
The Journal of infectious diseases 1980;142(1):67-71.
1980: I D Gust; S M Feinstone; Robert Purcell; Harvey Alter
Detection of antibodies to single-stranded DNA in naturally acquired and experimentally induced viral hepatitis.
Journal of medical virology 1980;6(1):1-10.
1980: H Popper; J L Dienstag; S M Feinstone; Harvey Alter; Robert Purcell
The pathology of viral hepatitis in chimpanzees.
Virchows Archiv. A, Pathological anatomy and histology 1980;387(1):91-106.
1980: Harvey Alter; P V Holland; Robert Purcell
Current status of posttransfusion hepatitis.
Pathobiology annual 1980;10():135-56.
1980: Harvey Alter
The dominant role of non-A, non-B in the pathogenesis of post-transfusion hepatitis: a clinical assessment.
Clinics in gastroenterology 1980;9(1):155-70.
1979: Y K Shimizu; S M Feinstone; Robert Purcell; Harvey Alter; W T London
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees.
Science (New York, N.Y.) 1979;205(4402):197-200.
1979: M Berman; Harvey Alter; K G Ishak; Robert Purcell; E A Jones
The chronic sequelae of non-A, non-B hepatitis.
Annals of internal medicine 1979;91(1):1-6.
1979: J L Dienstag; A K Bhan; Harvey Alter; S M Feinstone; Robert Purcell
Circulating immune complexes in non-A, non-B hepatitis. Possible masking of viral antigen.
Lancet 1979;1(8129):1265-7.
1978: T E Spiro; R Jaffe; P V Holland; Harvey Alter
A study of street heroin lots for the presence of the hepatitis B surface antigen.
Drug and alcohol dependence 1978;3(6):393-7.
1978: Harvey Alter; E Tabor; H T Meryman; J H Hoofnagle; R A Kahn; P V Holland; R J Gerety; L F Barker
Transmission of hepatitis V virus infection by transfusion of frozen-deglycerolized red blood cells.
The New England journal of medicine 1978;298(12):637-42.
1978: Harvey Alter; Robert Purcell; P V Holland; H Popper
Transmissible agent in non-A, non-B hepatitis.
Lancet 1978;1(8062):459-63.
1978: L B Seeff; E C Wright; H J Zimmerman; Harvey Alter; A A Dietz; B F Felsher; J D Finkelstein; P Garcia-Pont; J L Gerin; H B Greenlee; J Hamilton; P V Holland; P M Kaplan; T Kiernan; R S Koff; C M Leevy; V J McAuliffe; N Nath; Robert Purcell; Eugene R Schiff; C C Schwartz; C H Tamburro; Z Vlahcevic; R Zemel; D S Zimmon
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study.
Annals of internal medicine 1978;88(3):285-93.
1977: R A Whitney; J R Ganaway; A M Allen; Harvey Alter; Robert Purcell; P V Holland
Failure to transmit human viral hepatitis types A and B to the congenitally athymic nude mouse.
Laboratory animal science 1977;27(6):1031.
1977: L L Reys; Robert Purcell; P V Holland; Harvey Alter
The relationship between hepatitis B virus infection and hepatic cell carcinoma in Mozambique.
Tropical and geographical medicine 1977;29(3):251-6.
1977: Harvey Alter; Robert Purcell; J L Gerin; W T London; P M Kaplan; V J McAuliffe; J Wagner; P V Holland
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen.
Infection and immunity 1977;16(3):928-33.
1977: J L Dienstag; H R Purcell; Harvey Alter; S M Feinstone; D C Wong; P V Holland
Non-A, non-B post-transfusion hepatitis.
Lancet 1977;1(8011):560-2.
1977: K Madaliński; P V Holland; Z Moraczewska; B Kalinowska; Harvey Alter
Subtypes of HBsAg in eastern and south-eastern Europe.
Vox sanguinis 1977;32(4):224-9.
1976: D E Koziol; Harvey Alter; J P Kirchner; P V Holland
The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg.
Journal of immunology (Baltimore, Md. : 1950) 1976;117(6):2260-2.
1976: Harvey Alter
Hepatitis B and the health worker: prospective studies in perspective.
Annals of internal medicine 1976;85(5):971-2.
1976: Harvey Alter; L B Seeff; P M Kaplan; V J McAuliffe; E C Wright; J L Gerin; Robert Purcell; P V Holland; H J Zimmerman
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.
The New England journal of medicine 1976;295(17):909-13.
1976: I K Rothman; Harvey Alter; G J Strewler
Delayed overt hemolytic transfusion reaction due to anti-U antibody.
Transfusion 1976;16(4):357-60.
1976: Robert Purcell; Harvey Alter; J L Dienstag
Non-A, non-B hepatitis.
The Yale journal of biology and medicine 1976;49(3):243-50.
1975: Harvey Alter; L F Barker; P V Holland
Editorial: Hepatitis B immune globulin: Evaluation of clinical trials and rationale for usage.
The New England journal of medicine 1975;293(21):1093-4.
1975: S C Steinberg; Harvey Alter; B G Leventhal
The risk of hepatitis transmission to family contacts of leukemia patients.
The Journal of pediatrics 1975;87(5):753-6.
1975: Harvey Alter; P V Holland; A G Morrow; Robert Purcell; S M Feinstone; Y Moritsugu
Clinical and serological analysis of transfusion-associated hepatitis.
Lancet 1975;2(7940):838-41.
1975: Harvey Alter; P V Holland; Robert Purcell
The emerging pattern of post-transfusion hepatitis.
The American journal of the medical sciences 1975;270(2):329-34.
1975: P V Holland; Harvey Alter
The clinical significance of hepatitis B virus antigens and antibodies.
The Medical clinics of North America 1975;59(4):849-55.
1975: S M Feinstone; A Z Kapikian; Robert Purcell; Harvey Alter; P V Holland
Transfusion-associated hepatitis not due to viral hepatitis type A or B.
The New England journal of medicine 1975;292(15):767-70.
1975: Harvey Alter; T C Chalmers; B M Freeman; J L Lunceford; T L Lewis; P V Holland; P A Pizzo; Paul H Plotz; W J Meyer
Health-care workers positive for hepatitis B surface antigen. Are their contacts at risk?
The New England journal of medicine 1975;292(9):454-7.
1974: R G Graw; H P Lohrmann; M I Bull; J Decter; G P Herzig; J M Bull; B G Leventhal; R A Yankee; R H Herzig; G R Krueger; W A Bleyer; M L Buja; M H McGinniss; Harvey Alter; J Whang-Peng; H R Gralnick; C H Kirkpatrick; E S Henderson
Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia.
Transplantation proceedings 1974;6(4):349-54.
1974: J Pintera; J Vacl; P V Holland; Harvey Alter
Some approaches to deciding HB Ag (Australia antigen) positivity by counterimmunoelectrophoresis.
Blut 1974;29(3):165-71.
1974: R D Aach; Harvey Alter; F B Hollinger; P V Holland; J J Lander; J L Melnick; J M Weiler
Risk of transfusing blood containing antibody to hepatitis-B surface antigen.
Lancet 1974;2(7874):190-3.
1974: Harvey Alter; P V Holland; Robert Purcell
Viral hepatitis. Light at the end of the tunnel.
JAMA : the journal of the American Medical Association 1974;229(3):293-4.
1974: C P Duvall; Harvey Alter; C E Rath
Hemoglobin catabolism following a hemolytic transfusion reaction in a patient with sickle cell anemia.
Transfusion 1974;14(4):382-7.
1974: P M Kaplan; J L Gerin; Harvey Alter
Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis.
Nature 1974;249(459):762-4.
1974: Jonathan Gold; Harvey Alter; P V Holland; J L Gerin; Robert Purcell
Passive hemagglutination assay for antibody to subtypes of hepatitis B antigen.
Journal of immunology (Baltimore, Md. : 1950) 1974;112(3):1100-6.
1973: Harvey Alter; P V Holland; Robert Purcell; J L Gerin
The Ausria test: critical evaluation of sensitivity and specificity.
Blood 1973;42(6):947-57.
1973: S V Feinman; B Berris; J C Sinclair; D M Wrobel; Harvey Alter; P V Holland
Relation of hepatitis-B-antigen subtypes in symptom-free carriers to geographical origin and liver abnormalities.
Lancet 1973;2(7834):867-9.
1973: Robert Purcell; D C Wong; Harvey Alter; P V Holland
Microtiter solid-phase radioimmunoassay for hepatitis B antigen.
Applied microbiology 1973;26(4):478-84.
1973: T L Lewis; Harvey Alter; T C Chalmers; P V Holland; Robert Purcell; D W Alling; D Young; L D Frenkel; S L Lee; M E Lamson
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel.
The New England journal of medicine 1973;289(13):647-51.
1973: J N Whitaker; P V Holland; Harvey Alter; W King Engel
Idiopathic inflammatory myopathy. Failure to detect hepatitis B antigen in serum and muscle.
Archives of neurology 1973;28(6):410-1.
1972: P V Holland; Harvey Alter; Robert Purcell; J J Lander; J T Sgouris; P J Schmidt
Hepatitis B antigen (HB Ag) and antibody (anti-HB Ag) in cold ethanol fractions of human plasma.
Transfusion 1972;12(6):363-70.
1972: Harvey Alter; P V Holland; Robert Purcell; J J Lander; S M Feinstone; A G Morrow; P J Schmidt
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.
Annals of internal medicine 1972;77(5):691-9.
1972: P V Holland; Robert Purcell; H Smith; Harvey Alter
Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis.
Journal of immunology (Baltimore, Md. : 1950) 1972;109(3):420-5.
1972: Paul H Plotz; Harvey Alter; P V Holland
Exposure to a food-handler with hepatitis B.
Lancet 1972;2(7772):333.
1972: H J Lander; P V Holland; Harvey Alter; R M Chanock; Robert Purcell
Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation.
JAMA : the journal of the American Medical Association 1972;220(8):1079-82.
1972: Harvey Alter; P V Holland; P J Schmidt; Paul H Plotz
Gamma-globulin for hepatitis-virus B. Prevention or extension?
Lancet 1972;1(7760):1110-1.
1972: W T London; Harvey Alter; J Lander; Robert Purcell
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen.
The Journal of infectious diseases 1972;125(4):382-9.
1972: Harvey Alter; H F Polesky; P V Holland
False positive tests for hepatitis-associated antigen in blood donors caused by antibodies to ruminant serum proteins.
Journal of immunology (Baltimore, Md. : 1950) 1972;108(2):358-69.
1972: P V Holland; Harvey Alter; H M Smith
Technics of HAA detection.
The New England journal of medicine 1972;286(3):158-9.
1971: Harvey Alter; N J Zvaifler; C E Rath
Interrelationship of rheumatoid arthritis, folic acid, and aspirin.
Blood 1971;38(4):405-16.
1971: T C Chalmers; Harvey Alter
Management of the asymptomatic carrier of the hepatitis-associated (Australia antigen. Tentative considerations of the clinical and public-health aspects.
The New England journal of medicine 1971;285(11):613-7.
1971: Harvey Alter; P V Holland; Robert Purcell
Counterelectrophoresis for detection of hepatitis--associated antigen: methodology and comparison with gel diffusion and complement fixation.
The Journal of laboratory and clinical medicine 1971;77(6):1000-10.
1971: J J Lander; Harvey Alter; Robert Purcell
Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique.
Journal of immunology (Baltimore, Md. : 1950) 1971;106(5):1166-71.
1971: P Holland; Harvey Alter; Robert Purcell; J T Sgouris
Hepatitis-associated antigen and antibody in cold ethanol fractionates of human blood.
Vox sanguinis 1971;20(5):464-5.
1971: Harvey Alter
The hepatitis-associated antigen. (Australia antigen).
American family physician 1971;3(1):72-9.
1970: Harvey Alter; P V Holland; P J Schmidt
Hepatitis-associated antigen. To test or not to test?
Lancet 1970;2(7664):142-3.
1966: Harvey Alter; Baruch S Blumberg
Further studies on a "new" human isoprecipitin system (Australia antigen).
Blood 1966;27(3):297-309.
1965: P V Holland; Harvey Alter; P J Schmidt
A data retrieval system for blood donor information.
Transfusion 1965;5(6):543-9.
1965: B S BLUMBERG; Harvey Alter; S VISNICH
AN ALKYLATING AGENT FOR MULTIPLE MYELOMA: MELPHALAN.
JAMA : the journal of the American Medical Association 1965;191():547-9.
1965: B S BLUMBERG; Harvey Alter; S VISNICH
A "NEW" ANTIGEN IN LEUKEMIA SERA.
JAMA : the journal of the American Medical Association 1965;191():541-6.
1964: Baruch S Blumberg; Harvey Alter; N M RIDDELL; M ERLANDSON
MULTIPLE ANTIGENIC SPECIFICITIES OF SERUM LIPOPROTEINS DETECTED WITH SERA OF TRANSFUSED PATIENTS.
Vox sanguinis 1964;9():128-45.